ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
Gitmo
|
43 |
9.8K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
43
|
9.8K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
Gitmo
|
18K |
10M |
8 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
18K
|
10M
|
8
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Receives AUD $11.17m R&D Advance
|
|
Gitmo
|
38 |
8.9K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
38
|
8.9K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
Gitmo
|
11K |
5.9M |
12 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
11K
|
5.9M
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: S&P DJI Announces March 2024 Quarterly Rebalance
|
|
Gitmo
|
4 |
2.0K |
1 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
4
|
2.0K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
Gitmo
|
18K |
10M |
2 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
18K
|
10M
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
Gitmo
|
53 |
12K |
6 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
53
|
12K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Establishes Strategic Partnership in South-East Asia
|
|
Gitmo
|
48 |
11K |
2 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
48
|
11K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gitmo
|
15 |
4.4K |
5 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
15
|
4.4K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gitmo
|
15 |
4.4K |
1 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
15
|
4.4K
|
1
|
|
ASX - By Stock
|
RMY |
Re:
Ann: Update on share sale restriction on co-founder
|
|
Gitmo
|
9 |
1.9K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
9
|
1.9K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Murdoch Children's R327 Efficacy UTI in-vivo
|
|
Gitmo
|
27 |
10K |
10 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
27
|
10K
|
10
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Awarded $43.7m AusIndustry Advanced Overseas Finding
|
|
Gitmo
|
32 |
9.7K |
8 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
32
|
9.7K
|
8
|
|
ASX - By Stock
|
RCE |
Re:
Ann: RCE Awarded $43.7m AusIndustry Advanced Overseas Finding
|
|
Gitmo
|
32 |
9.7K |
2 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
32
|
9.7K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
Gitmo
|
18K |
10M |
9 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
18K
|
10M
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Gitmo
|
20K |
6.8M |
0 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
20K
|
6.8M
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Results of Meeting
|
|
Gitmo
|
6 |
2.1K |
6 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
6
|
2.1K
|
6
|
|
ASX - By Stock
|
PNV |
Re:
Ann: AGM - Chairman and CEO address to shareholders
|
|
Gitmo
|
70 |
26K |
11 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
70
|
26K
|
11
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Entitlement Offer - Announcement of Results
|
|
Gitmo
|
13 |
5.3K |
5 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
13
|
5.3K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Entitlement Offer - Announcement of Results
|
|
Gitmo
|
13 |
5.3K |
2 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
13
|
5.3K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Becoming a substantial holder
|
|
Gitmo
|
18 |
5.5K |
2 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
18
|
5.5K
|
2
|
|
ASX - By Stock
|
RMY |
Re:
Ann: Director Appointment/Resignation
|
|
Gitmo
|
4 |
1.1K |
0 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
4
|
1.1K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
Gitmo
|
11K |
5.9M |
1 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
11K
|
5.9M
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
Gitmo
|
66 |
17K |
6 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
66
|
17K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
Gitmo
|
66 |
17K |
5 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
66
|
17K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Appendix 4E and Unaudited Preliminary Report
|
|
Gitmo
|
20 |
6.0K |
2 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
20
|
6.0K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Appendix 4E and Unaudited Preliminary Report
|
|
Gitmo
|
20 |
6.0K |
5 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
20
|
6.0K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Additional Positive Patient Cases - Special Access Scheme
|
|
Gitmo
|
24 |
7.1K |
0 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
24
|
7.1K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Appendix 4E and Unaudited Preliminary Report
|
|
Gitmo
|
20 |
6.0K |
0 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
20
|
6.0K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Webcast Details - FY23 Results
|
|
Gitmo
|
120 |
35K |
2 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
120
|
35K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Webcast Details - FY23 Results
|
|
Gitmo
|
120 |
35K |
3 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
120
|
35K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
Gitmo
|
450 |
141K |
7 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
450
|
141K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
Gitmo
|
450 |
141K |
1 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
141K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I/II Burn Wound Infection Trial Stage 1 Complete
|
|
Gitmo
|
16 |
5.8K |
5 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
16
|
5.8K
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Vale Wombat777
|
|
Gitmo
|
68 |
33K |
10 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
68
|
33K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
Gitmo
|
592 |
178K |
2 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
592
|
178K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Gitmo
|
124 |
38K |
17 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
124
|
38K
|
17
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Gitmo
|
124 |
38K |
18 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
124
|
38K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Gitmo
|
1.0K |
386K |
1 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
386K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Gitmo
|
1.0K |
386K |
15 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
386K
|
15
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gitmo
|
45 |
13K |
0 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
45
|
13K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gitmo
|
45 |
13K |
2 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
45
|
13K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gitmo
|
45 |
13K |
7 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
45
|
13K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gitmo
|
45 |
13K |
1 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
45
|
13K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gitmo
|
45 |
13K |
1 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
45
|
13K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gitmo
|
45 |
13K |
2 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
45
|
13K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Scientia Doses Ahead of Schedule in Phase I/II UTI Trial
|
|
Gitmo
|
25 |
6.7K |
5 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
25
|
6.7K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
[INTERVIEW] CEO buys another $300,000 stake in Recce Pharmaceuticals (ASX:RCE)
|
|
Gitmo
|
38 |
11K |
1 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
38
|
11K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: A$801,604 R&D Rebate Advance Received
|
|
Gitmo
|
2 |
1.0K |
4 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
2
|
1.0K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
30th June 2024 Share Price Prediction
|
|
Gitmo
|
202 |
67K |
5 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
202
|
67K
|
5
|
|